Overall rank by patents
#49,982
of 49,997 tracked assignees
USPTO PatentsView assignee record - 5 granted patents across 2 technology areas, recorded in grant years 2023–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data).
The verdict
According to USPTO PatentsView, Reviv ranks #49,982 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 2 technology areas.
USPTO PatentsView assignee plate
Corpus R49982 · Foreign Corporation #49,982 · 5 grants
GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH
Nearest grant-volume peer: REscan, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Club Car · near
43 score
Kindred Systems · near
43 score
Pfaqutruma Research · near
43 score
Reviv Global · this assignee
43 score
Siluria · near
43 score
3D Lighting… · lowest
7 score
What this shows Reviv's Innovation Score is 43.1/100 (top 29% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Reviv Global Ltd is a focused PatentsView assignee: 2 CPC subclasses with 100% of grants classified under G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data). Peak complete grant year is 2024 (2 grants) versus a trough of 1 in 2023. By volume, Reviv sits between Responsys, Inc. and Rfph, LLC.
Reviv Global Ltd shows 3 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Responsys, Inc.
5 patents
Restone AS
5 patents
Reveal Biosensors, Inc.
5 patents
Reviral Limited
5 patents
Revolutionary Plastics, LLC
5 patents
Reyoung (SUZHOU) Biology Science & Technology Co., Ltd
5 patents
REscan, Inc.
5 patents
Rfph, LLC
5 patents
Reviv Global Ltd
5 patents
What this shows Reviv holds 5 patents at rank #49,986, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #49,986 in granted patent volume.
Other assignees with the most granted patents in Reviv's primary technology class.
Two PlainPatent-derived peer sets for Reviv, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (43 here).
Reviv's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
43 Top 29% higher than 71% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2023 | 1 | 20.0% |
| 2024 | 2 | 40.0% |
| 2025partial year | 2 | 40.0% |
Top 2 of 2 technology areas
Overall rank by patents
#49,982
of 49,997 tracked assignees
43.1 out of 100
What to do with this data
Reviv Global Ltd's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.